Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies-Reference-Cited by-同舟云学术

Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies

Published:2022-01 Issue: Volume:57 Page:103332
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Levy Michael,Haycox Alan R.,Becker Ursula,Costantino Cristina,Damonte Elisabetta,Klingelschmitt Gaelle,von Büdingen H. Christian,Wallenstein Gene,Maio D. Di,Szczechowski Lech

Funder

F Hoffmann-La Roche Ltd

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference47 articles.

1. Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies;Bansback;PLoS One,2012

2. Neuromyelitis optica spectrum disorder. Patient experience and quality of life;Beekman;Neurol. Neuroimmunol. Neuroinflamm.,2019

3. Antiepileptic and antidepressive polypharmacy in patients with multiple sclerosis;Beiske;Mult. Scler. Int.,2015

4. Influence of female sex and fertile age on neuromyelitis optica spectrum disorders;Borisow;Mult. Scler.,2017

5. Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis;Borisow;Front. Neurol.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In patients with mild disability NMOSD: is the alteration in the cortical morphological or functional network topological properties more significant;Frontiers in Immunology;2024-02-05

2. Measuring the economic burden of neuromyelitis optica spectrum disorder in Colombia;Multiple Sclerosis and Related Disorders;2024-02

3. Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD;Frontiers in Neurology;2024-01-26

4. Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to care;Neurological Sciences;2023-11-03

5. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management;Journal of Neurology;2023-09-07